Liraglutide In Overweight Patients With Type 1 Diabetes
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of liraglutide (a drug used to treat type
2 diabetes) on glucose (sugar) control over the 26 week study period when used in addition to
insulin.
Phase:
Phase 3
Details
Lead Sponsor:
University at Buffalo
Collaborators:
Juvenile Diabetes Research Foundation Kaleida Health